The 2026 Market Junk Drawer: From Space Hype to Casino NightmaresGlobal Report·Aug 11 at 05:12 AMWTI+1.09%THC-0.81%
LKFT: Returned to profitability in H1 2026 with €16.6M net profit and robust €2.24B cash positionQuartr·Aug 11 at 12:16 AMLKFT+0.22%
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Posts Earnings Results, Beats Expectations By $1.01 EPSMarket Beat·Aug 10 at 04:56 PMLKFT+0.22%
Lakefront Biotherapeutics H1 FY26 net sales drop 87% to EUR 18.6 million; operating loss narrows 54% to EUR 107.2 millionPUBT·Aug 10 at 03:04 PMLKFT+0.22%GILD+0.30%
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business UpdateUnusual Whales·Aug 10 at 03:02 PMLKFT+0.22%GILD+0.30%
Lakefront Biotherapeutics Buys Back 97,497 Shares Under Ongoing Repurchase ProgramTip Ranks·Aug 4 at 03:33 PMLKFT+0.22%
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Sets New 52-Week Low - Here's What HappenedMarket Beat·Aug 3 at 12:40 PMLKFT+0.22%
The Island of Misfit Stocks: Cash Cows and SleepwalkersGlobal Report·Jul 22 at 04:18 AMRGC-1.93%LKFT+0.22%
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at SanofiUnusual Whales·Jul 13 at 03:03 PMLKFT+0.22%SNY+1.30%
Lakefront Biotherapeutics director Paulo Fontoura steps down after taking Sanofi R&D chief rolePUBT·Jul 13 at 03:01 PMLKFT+0.22%SNY+1.30%
Lakefront Biotherapeutics Buys Back Over 104,000 Shares Under June 2026 Repurchase ProgramTip Ranks·Jul 7 at 03:47 PMLKFT+0.22%
Lakefront Receives Transparency Notification from Madison Avenue PartnersUnusual Whales·Jun 29 at 03:02 PMLKFT+0.22%
Madison Avenue Partners discloses 5.31% stake in Lakefront BiotherapeuticsPUBT·Jun 29 at 03:01 PMLKFT+0.22%
Lakefront Biotherapeutics repurchases own stock for EUR 1.92 millionPUBT·Jun 23 at 03:01 PMLKFT+0.22%
